Answers are grounded in this paper and cite their sources.
The structures of new antitumor antibiotics, glidobactins A (Ia), B (Ib) and C (Ic) were elucidated by a combination of chemical and enzymatic degradations and spectral analyses. They have in common a cyclized tripeptide nucleus composed of L-threonine, 4(S)-amino-2(E)-pentenoic acid and erythro-4-hydroxy-L-lysine, and differ from each other in the unsaturated fatty acid moiety attached to the peptide.
No takes yet. Share an insight, caveat, or question.
OKA et al. (1988) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: